VC
AXDX icon

Vestor Capital’s Accelerate Diagnostics AXDX Stock Holding History

Vestor Capital’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-745
Closed -$160K – 111
2014
Q3 		$160K Buy
+745
New +$145K 0.05% 64

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Obermeyer Wealth Partners
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vestor Capital's AXDX Position: Q4 2014 in Review

Vestor Capital sold out of Accelerate Diagnostics (AXDX) in Q4 2014, closing a stake of 745 shares — an estimated $160K sold.

Vestor Capital first reported a position in AXDX in Q3 2014 and held it in 1 quarter. The position peaked at $160K in Q3 2014. 78 funds tracked by Wall St. Rank hold AXDX as of Q4 2014.

  • Vestor Capital reported no remaining Accelerate Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Vestor Capital sold 745 Accelerate Diagnostics shares in Q4 2014, an estimated $160K.
  • Vestor Capital first reported a position in Accelerate Diagnostics in Q3 2014 and held it in 1 quarter.
  • Vestor Capital's Accelerate Diagnostics position peaked at $160K in Q3 2014.
  • 78 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2014.

Based on Vestor Capital's 13F filing for Q4 2014, filed 29 Jan 2015.